May 13 (Reuters)-
OncoTherapy Science Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 266 mln 769 mln
(-65.3 pct) (-24.3 pct)
Operating loss 2.98 loss 1.96
Recurring loss 2.96 loss 1.94
Net
Net loss 2.79 loss 1.33
EPS loss 18.97 yen loss 9.09 yen
Ann Div NIL NIL NIL
-Q2 Div
-Q4 Div NIL NIL NIL
NOTE - OncoTherapy Science Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T
((Tokyo Headline News Desk +813 6441 1812))